trastuzumab [Herceptin]
ML25477
Approved small_molecule terminated
Quick answer
trastuzumab [Herceptin] for Gastric Cancer is a Approved program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Gastric Cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated